Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors
US8329715B2 · kind B2 · utility
8Cited by
2References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 2, 2012 |
| Grant date | Dec 11, 2012 |
| Priority date | — |
| Expiry date | Mar 2, 2032 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to chemical compounds of Formula (I) are as herein defined, pharmaceutical compositions, and methods of use in the treatment of conditions or disorders mediated by TNF-α or by PDE4, including but not limited to rheumatoid arthritis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.